Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiotherapeutics company with operations in Europe and China. We seek to own the entire value chain for radio-ligand production, research, development & commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack core issues that exist in radiopharmaceuticals today including innovative translational & biology research platform targeting the radiopharma treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs & scientists with demonstrated track record in life science company building as well as radioisotope research and clinical development. From Half-Life to Full-Life.